In this week’s edition of InnovationRx, we look at the dangers of RFK Jr.’s vaccine advisory committee, how Trump’s visa ban ...

Scientists have discovered the internal shape of tiny drug-delivery particles - called lipid nanoparticles - has a big impact ...

Damola Adamolekun was hired in 2024 to lead the restaurant chain’s revival after filing for bankruptcy. He details the progress being made in the turnaround, while detailing the challenges posed by ...

One trend that the biotech industry in Europe has witnessed of late is the move towards climate ... This, coupled with the EU AI Act – the regulatory framework concerning AI in the EU – is part of a ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Gene editing’s real value is not in re-creating copies of long-extinct species like dire wolves, but instead using it to ...

A BU professor warns that federal funding cuts, immigration restrictions and housing costs could reshape the region's status ...

The biotech industry’s largest annual conclave ... “More prevalent diseases are red hot,” he said, including obesity, heart failure, immunology and inflammation. Sha added, “There ...

At first it was dismissed as a crazy joke. Making the Enhanced Games a reality needed a Peter Thiel posse, a couple of ...

FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA”—one that would decide on drug applications much faster, ...

FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” with biopharma leaders attending BIO in Boston.

Pfizer CEO Albert Bourla, Ph.D., has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing ...